WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RPTX

Based on 1 analyst offering 12 month price targets for Repare Therapeutics Inc.
Min Forecast
$10.00+189.02%
Avg Forecast
$10.00+189.02%
Max Forecast
$10.00+189.02%

Should I buy or sell RPTX stock?

Based on 1 analyst offering ratings for Repare Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RPTX stock forecasts and price targets.

RPTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-23

1 of 1

Forecast return on equity

Is RPTX forecast to generate an efficient return?
Company
-48.76%
Industry
-762.05%
Market
49.3%
RPTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RPTX forecast to generate an efficient return on assets?
Company
-42.2%
Industry
26.89%
RPTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RPTX earnings per share forecast

What is RPTX's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$2.15
Avg 2 year Forecast
-$3.20
Avg 3 year Forecast
-$2.88

RPTX revenue forecast

What is RPTX's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$59.9M-12.72%
Avg 2 year Forecast
$21.7M-68.4%
Avg 3 year Forecast
$35.6M-48.2%
RPTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RPTX revenue growth forecast

How is RPTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-27.46%
Industry
36.05%
Market
9.61%
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RPTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RPTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RPTX$3.46$10.00+189.02%Buy
INO$5.65$19.00+236.28%Buy
PDSB$3.96$15.00+278.79%Strong Buy
VTYX$2.06$10.25+397.57%Strong Buy
CNTX$1.98$6.83+245.10%Strong Buy
View Top Biotech Stocks

Repare Therapeutics Stock Forecast FAQ

Is Repare Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RPTX) stock is to Buy RPTX stock.

Out of 1 analyst, 0 (0%) are recommending RPTX as a Strong Buy, 1 (100%) are recommending RPTX as a Buy, 0 (0%) are recommending RPTX as a Hold, 0 (0%) are recommending RPTX as a Sell, and 0 (0%) are recommending RPTX as a Strong Sell.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.

What is RPTX's earnings growth forecast for 2024-2026?

(NASDAQ: RPTX) Repare Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.13%.

Repare Therapeutics's earnings in 2024 is -$68,521,000.On average, 6 Wall Street analysts forecast RPTX's earnings for 2024 to be -$91,257,896, with the lowest RPTX earnings forecast at -$97,200,271, and the highest RPTX earnings forecast at -$82,344,334. On average, 6 Wall Street analysts forecast RPTX's earnings for 2025 to be -$135,897,863, with the lowest RPTX earnings forecast at -$158,746,293, and the highest RPTX earnings forecast at -$114,602,939.

In 2026, RPTX is forecast to generate -$122,103,065 in earnings, with the lowest earnings forecast at -$160,444,115 and the highest earnings forecast at -$73,006,317.

What is RPTX's revenue growth forecast for 2024-2026?

(NASDAQ: RPTX) Repare Therapeutics's forecast annual revenue growth rate of -27.46% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.61%.

Repare Therapeutics's revenue in 2024 is $68,683,000.On average, 7 Wall Street analysts forecast RPTX's revenue for 2024 to be $2,544,524,812, with the lowest RPTX revenue forecast at $2,270,836,016, and the highest RPTX revenue forecast at $3,042,495,805. On average, 4 Wall Street analysts forecast RPTX's revenue for 2025 to be $921,152,957, with the lowest RPTX revenue forecast at $339,564,264, and the highest RPTX revenue forecast at $1,697,821,320.

In 2026, RPTX is forecast to generate $1,510,084,728 in revenue, with the lowest revenue forecast at $798,400,476 and the highest revenue forecast at $3,119,746,676.

What is RPTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RPTX) forecast ROA is -42.2%, which is lower than the forecast US Biotechnology industry average of 26.89%.

What is RPTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RPTX price target, the average RPTX price target is $10.00, with the highest RPTX stock price forecast at $10.00 and the lowest RPTX stock price forecast at $10.00.

The Wall Street analyst predicted that Repare Therapeutics's share price could reach $10.00 by Sep 23, 2025. The average Repare Therapeutics stock price prediction forecasts a potential upside of 189.02% from the current RPTX share price of $3.46.

What is RPTX's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: RPTX) Repare Therapeutics's current Earnings Per Share (EPS) is -$1.63. On average, analysts forecast that RPTX's EPS will be -$2.15 for 2024, with the lowest EPS forecast at -$2.29, and the highest EPS forecast at -$1.94. On average, analysts forecast that RPTX's EPS will be -$3.20 for 2025, with the lowest EPS forecast at -$3.74, and the highest EPS forecast at -$2.70. In 2026, RPTX's EPS is forecast to hit -$2.88 (min: -$3.78, max: -$1.72).

What is RPTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RPTX) forecast ROE is -48.76%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.